Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Janus kinase inhibitors are effective for the treatment of rheumatoid arthritis, but might they increase the risk of cardiovascular and venous thromboembolic events?
A better understanding of the factors contributing to well-being and burnout among rheumatologists could help drive future interventions to address these issues.
A new analysis investigates the potential for patients with rheumatoid arthritis to experience adverse events after treatment with immune checkpoint inhibitors.
Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison With Adult Patients: Analysis From a Multicentric Cohort in Spain.